Atrial Fibrillation and Heart Failure: Update 2015

作者：Thihalolipavan Sudarone; Morin Daniel P^*

来源：Progress in Cardiovascular Diseases, 2015, 58(2): 126-135.

DOI：10.1016/j.pcad.2015.07.004

• Atrial fibrillation
• Heart failure
• Anti-arrhythmia drugs
• Catheter ablation
• Anticoagulation

Heart failure (HF) and atrial fibrillation (AF) commonly coexist, adversely affect mortality, and impose a significant burden on healthcare resources. The presence of AF and HF portends a poor prognosis as well as an increased thromboembolic risk In patients whose AF is symptomatic, rhythm restoration with either antiarrhythmic drugs or procedural therapies (e.g., pulmonary vein isolation, either catheter-based or surgical) should be considered for symptom improvement, though a mortality benefit has yet to be demonstrated. Emerging evidence suggests that non-pharmacological treatment for AF (including catheter based ablation, hybrid surgical techniques, and attioventricular node ablation with biventricular pacing) may be of value in improving HF patients' quality of life.

• 出版日期2015-10